Simplex Trading, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 13,474 shares of ARWR stock, worth $264,494. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,474

Previous 14,220 5.25%

Holding current value

$264,494

Previous $369,000 29.54%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$19.36 - $29.54 $14,442 - $22,036	-746 Reduced 5.25%	13,474 $260,000
Q2 2024 Jul 25, 2024	SELL	$21.87 - $28.24 $148,519 - $191,777	-6,791 Reduced 32.32%	14,220 $369,000
Q1 2024 Apr 25, 2024	BUY	$27.21 - $39.48 $50,801 - $73,709	1,867 Added 9.75%	21,011 $600,000
Q4 2023 Feb 02, 2024	BUY	$21.2 - $31.03 $405,852 - $594,038	19,144 New	19,144 $585,000
Q2 2023 Aug 04, 2023	SELL	$25.16 - $41.38 $27,248 - $44,814	-1,083 Reduced 60.64%	703 $25,000
Q1 2023 Apr 27, 2023	BUY	$23.68 - $38.51 $42,292 - $68,778	1,786 New	1,786 $45,000
Q3 2022 Nov 04, 2022	SELL	$29.63 - $48.31 $1,422 - $2,318	-48 Reduced 1.47%	3,222 $106,000
Q2 2022 Aug 03, 2022	BUY	$27.79 - $50.61 $20,064 - $36,540	722 Added 28.34%	3,270 $115,000
Q1 2022 May 02, 2022	SELL	$39.62 - $69.97 $806,425 - $1.42 Million	-20,354 Reduced 88.87%	2,548 $117,000
Q4 2021 Feb 23, 2022	SELL	$58.09 - $82.51 $546,568 - $776,336	-9,409 Reduced 29.12%	22,902 $1.52 Million
Q3 2021 Oct 28, 2021	BUY	$58.38 - $84.96 $257,747 - $375,098	4,415 Added 15.83%	32,311 $2.75 Million
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $183,591 - $266,805	-2,954 Reduced 9.58%	27,896 $2.31 Million
Q1 2021 Apr 26, 2021	BUY	$61.35 - $90.47 $278,344 - $410,462	4,537 Added 17.24%	30,850 $0
Q4 2020 Feb 02, 2021	SELL	$43.82 - $85.37 $749,365 - $1.46 Million	-17,101 Reduced 39.39%	26,313 $2.02 Million
Q3 2020 Oct 14, 2020	SELL	$33.21 - $51.27 $7,970 - $12,304	-240 Reduced 0.55%	43,414 $1.87 Million
Q2 2020 Jul 13, 2020	SELL	$26.12 - $43.27 $60,859 - $100,819	-2,330 Reduced 5.07%	43,654 $1.89 Million
Q1 2020 Apr 29, 2020	BUY	$20.56 - $63.12 $424,461 - $1.3 Million	20,645 Added 81.48%	45,984 $1.32 Million
Q4 2019 Feb 05, 2020	SELL	$28.14 - $73.01 $189,382 - $491,357	-6,730 Reduced 20.99%	25,339 $1.61 Million
Q3 2019 Oct 15, 2019	SELL	$26.26 - $34.86 $391,510 - $519,727	-14,909 Reduced 31.74%	32,069 $903,000
Q2 2019 Jul 26, 2019	BUY	$17.43 - $28.82 $664,117 - $1.1 Million	38,102 Added 429.27%	46,978 $1.24 Million
Q1 2019 Apr 18, 2019	SELL	$12.05 - $20.18 $28,377 - $47,523	-2,355 Reduced 20.97%	8,876 $0
Q4 2018 Jan 16, 2019	BUY	$10.74 - $19.7 $45,720 - $83,862	4,257 Added 61.04%	11,231 $139,000
Q3 2018 Oct 23, 2018	SELL	$14.0 - $20.3 $745,010 - $1.08 Million	-53,215 Reduced 88.41%	6,974 $133,000
Q2 2018 Jul 30, 2018	BUY	$6.37 - $14.02 $315,799 - $695,055	49,576 Added 467.13%	60,189 $818,000
Q1 2018 Apr 26, 2018	BUY	$3.72 - $7.64 $39,480 - $81,083	10,613 New	10,613 $76,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Arrowhead Pharmaceuticals, Inc. Transaction History